In8bio, Inc. (INAB) — 10-K/A Filings
All 10-K/A filings from In8bio, Inc.. Browse 1 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (1)
-
IN8BIO, INC. Files 2024 Annual Report Amendment
— May 7, 2025 Risk: medium
IN8BIO, INC. filed an amendment (10-K/A) on May 7, 2025, for its fiscal year ended December 31, 2024. The company, formerly known as Incysus Therapeutics, Inc.,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX